Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Auton Autacoid Pharmacol ; 32(1 Pt 2): 1-7, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21843205

RESUMEN

In cardiac surgery, agents are needed to produce temporary cardiac arrest (cardioplegia). One of these agents is esmolol (ESM) which is a short-acting selective beta-1 adrenergic receptor antagonist and its overdose causes diastolic ventricular arrest. The (25) MgPMC(16) (porphyrin adducts of cyclohexil fullerene-C60) is known as a nanoparticle which has a cardioprotective effect when the heart is subjected to stressful conditions. In this study, we aimed to confirm the deleterious effects of ESM overdose on cardiac mitochondria and identify any protective effects of (25) MgPMC(16) in male Wistar rats. Esmolol 100 mg kg(-1) (LD50 = 71 mg kg(-1) ) was injected intravenously (i.v.) into tail vein to induce cardiac arrest. This dose was obtained from an ESM dose-response curve which induces at least 80% arrest in rats. (25) MgPMC(16) at three different doses (45, 90 and 224 mg kg(-1) ) was injected i.v. as pretreatment, eight hours before ESM injection. (25) MgCl(2) or (24) MgPMC(16) were used as controls. Following cardiac arrest, the heart was removed and the mitochondria extracted. Mitochondrial viability and the adenosine 5'-diphosphate sodium salt hydrate/Adenosine 5'-triphosphate disodium salt hydrate (ADP/ATP) ratio were measured as biomarkers of mitochondrial function. Results indicate that (25) MgPMC(16) caused a significant increase in mitochondrial viability and decrease in ADP/ATP ratio. No significant changes were seen with (24) MgPMC(16) or (25) MgCl(2) . It is concluded that cardiac arrest induced by ESM overdose leads to a significant decrease in mitochondrial viability and their ATP levels, whereas pretreatment by (25) MgPMC(16) can protect mitochondria by increasing ATP level through liberation of Mg into cells and the improvement of hypoxia.


Asunto(s)
Paro Cardíaco/prevención & control , Magnesio/uso terapéutico , Nanopartículas del Metal , Enfermedades Mitocondriales/prevención & control , Porfirinas/farmacología , Propanolaminas/toxicidad , Animales , Cardiotónicos/farmacología , Cardiotónicos/uso terapéutico , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Paro Cardíaco/inducido químicamente , Paro Cardíaco/metabolismo , Isótopos , Magnesio/metabolismo , Masculino , Nanopartículas del Metal/uso terapéutico , Enfermedades Mitocondriales/metabolismo , Enfermedades Mitocondriales/patología , Porfirinas/uso terapéutico , Distribución Aleatoria , Ratas , Ratas Wistar
3.
Int J Nanomedicine ; 6: 855-62, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21720498

RESUMEN

Silver has been used as an antimicrobial agent for a long time in different forms, but silver nanoparticles (nanosilver) have recently been recognized as potent antimicrobial agents. Although nanosilver is finding diverse medical applications such as silver-based dressings and silver-coated medical devices, its dermal and systemic toxicity via dermal use has not yet been identified. In this study, we analyzed the potential toxicity of colloidal nanosilver in acute and subchronic guinea pigs. Before toxicity assessments, the size of colloidal nanosilver was recorded in sizes <100 nm by X-ray diffraction and transmission electron microscopy. For toxicological assessments, male guinea pigs weighing 350 to 400 g were exposed to two different concentrations of nanosilver (1000 and 10,000 µg/mL) in an acute study and three concentrations of nanosilver (100, 1000, and 10,000 µg/mL) in a subchronic study. Toxic responses were assessed by clinical and histopathologic parameters. In all experimental animals the sites of exposure were scored for any type of dermal toxicity and compared with negative control and positive control groups. In autopsy studies during the acute test, no significant changes in organ weight or major macroscopic changes were detected, but dose-dependent histopathologic abnormalities were seen in skin, liver, and spleen of all test groups. In addition, experimental animals subjected to subchronic tests showed greater tissue abnormalities than the subjects of acute tests. It seems that colloidal nanosilver has the potential to provide target organ toxicities in a dose- and time-dependent manner.


Asunto(s)
Nanoestructuras/toxicidad , Plata/toxicidad , Piel/efectos de los fármacos , Animales , Coloides , Relación Dosis-Respuesta a Droga , Cobayas , Histocitoquímica , Inflamación , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Microscopía Electrónica de Transmisión , Nanoestructuras/administración & dosificación , Tamaño de la Partícula , Plata/administración & dosificación , Piel/patología , Bazo/efectos de los fármacos , Bazo/patología , Pruebas de Toxicidad Aguda , Difracción de Rayos X
4.
J Environ Biol ; 28(3): 527-31, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18380070

RESUMEN

The carbohydrate contents of sweet sorghum (Sorghum bicolor L. Moench) is an important industrial factor for crystal sugar or bioethanol production. In this study the relationship between growth analysis and carbohydrate contents were studied to recognize the best growth stages for sweet sorghum harvesting. Five sweet sorghum cultivars and four sweet sorghum lines were evaluated for leaf area index (LAI), net assimilation rate (NAR), relative growth rate (RGR) and stem crop growth rate (CGR) in relation to sucrose content, invert sugars and total sugar at booting, soft-dough, hard dough and post grain maturity Except at post grain maturitystage, the correlations among LAI, NAR and RGR forsucrose content and total sugar were positive and forinvert sugars were negative. The relationship between invert sugars including glucose, fructose, maltose and xylose athard dough stage regarding LAI, NAR and GRG were negative. As plant grows LAI, NAR and RGR increases which consequently increases sucroses content and decrease invert sugar.


Asunto(s)
Metabolismo de los Hidratos de Carbono , Sorghum/crecimiento & desarrollo , Sorghum/metabolismo , Hojas de la Planta/crecimiento & desarrollo , Tallos de la Planta/crecimiento & desarrollo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA